eszopiclone

This page covers all eszopiclone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Gamma-aminobutyric acid receptor subunit alpha-1.

Targets

Gamma-aminobutyric acid receptor subunit alpha-1

Marketed (1)

• Lunesta · Waylis · Neuroscience
  Lunesta works by enhancing the activity of a neurotransmitter called GABA, which helps calm the brain and promote sleep.

Patent intelligence

• eszopiclone patent landscape — aggregated cliff calendar, attackable patents, originator estates